Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| cardiac muscle cell | 6 studies | 67% ± 21% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| heart | 4 studies | 31% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| muscle | 100% | 37288.47 | 803 / 803 | 0% | 0 | 0 / 0 |
| heart | 99% | 12356.15 | 854 / 861 | 0% | 0 | 0 / 0 |
| blood vessel | 56% | 1629.35 | 749 / 1335 | 0% | 0 | 0 / 0 |
| stomach | 20% | 148.63 | 71 / 359 | 11% | 0.45 | 31 / 286 |
| liver | 0% | 0 | 0 / 226 | 17% | 0.99 | 71 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 17% | 1.36 | 5 / 29 |
| bladder | 5% | 31.90 | 1 / 21 | 9% | 0.29 | 45 / 504 |
| esophagus | 2% | 24.17 | 24 / 1445 | 12% | 0.54 | 22 / 183 |
| prostate | 6% | 129.78 | 14 / 245 | 7% | 0.47 | 34 / 502 |
| breast | 1% | 17.53 | 5 / 459 | 10% | 0.26 | 116 / 1118 |
| tonsil | 0% | 0 | 0 / 0 | 11% | 0.71 | 5 / 45 |
| lung | 1% | 12.47 | 4 / 578 | 9% | 0.31 | 99 / 1155 |
| uterus | 0% | 0 | 0 / 170 | 8% | 0.70 | 39 / 459 |
| skin | 1% | 39.03 | 21 / 1809 | 6% | 0.32 | 30 / 472 |
| thymus | 1% | 11.54 | 5 / 653 | 4% | 0.25 | 27 / 605 |
| adrenal gland | 0% | 2.87 | 1 / 258 | 4% | 0.07 | 10 / 230 |
| pancreas | 1% | 3.55 | 2 / 328 | 3% | 0.11 | 6 / 178 |
| intestine | 0% | 0.55 | 1 / 966 | 4% | 0.16 | 20 / 527 |
| ovary | 0% | 0 | 0 / 180 | 2% | 0.07 | 10 / 430 |
| peripheral blood | 2% | 28.39 | 20 / 929 | 0% | 0 | 0 / 0 |
| brain | 0% | 0.22 | 1 / 2642 | 1% | 0.03 | 10 / 705 |
| eye | 0% | 0 | 0 / 0 | 1% | 0.09 | 1 / 80 |
| adipose | 1% | 6.07 | 9 / 1204 | 0% | 0 | 0 / 0 |
| kidney | 0% | 0 | 0 / 89 | 1% | 0.03 | 6 / 901 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0001570 | Biological process | vasculogenesis |
| GO_0055013 | Biological process | cardiac muscle cell development |
| GO_0001701 | Biological process | in utero embryonic development |
| GO_0031032 | Biological process | actomyosin structure organization |
| GO_0016460 | Cellular component | myosin II complex |
| GO_0032982 | Cellular component | myosin filament |
| GO_0030018 | Cellular component | Z disc |
| GO_0016461 | Cellular component | unconventional myosin complex |
| GO_0031941 | Cellular component | filamentous actin |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0003774 | Molecular function | cytoskeletal motor activity |
| GO_0051015 | Molecular function | actin filament binding |
| GO_0005524 | Molecular function | ATP binding |
| Gene name | MYO18B |
| Protein name | Myosin XVIIIB Unconventional myosin-XVIIIb Alternative protein MYO18B |
| Synonyms | |
| Description | FUNCTION: May be involved in intracellular trafficking of the muscle cell when in the cytoplasm, whereas entering the nucleus, may be involved in the regulation of muscle specific genes. May play a role in the control of tumor development and progression; restored MYO18B expression in lung cancer cells suppresses anchorage-independent growth. |
| Accessions | ENST00000536101.5 [Q8IUG5-1] L8EAK4 Q8IUG5 F5H6I8 H0YGQ4 ENST00000543971.1 ENST00000407587.6 [Q8IUG5-3] ENST00000540454.1 A0A2Q2TCQ6 ENST00000335473.12 [Q8IUG5-1] ENST00000539302.5 |